An overview of antibody–drug conjugates in oncological practice

por Theocharopoulos, Charalampos, Lialios, Panagiotis-Petros, Gogas, Helen, Ziogas, Dimitrios C.
Publicado 2020

Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond

por Theocharopoulos, Charalampos, Lialios, Panagiotis-Petros, Samarkos, Michael, Gogas, Helen, Ziogas, Dimitrios C.
Publicado 2021

Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment

por Ziogas, Dimitrios C., Theocharopoulos, Charalampos, Lialios, Panagiotis-Petros, Foteinou, Dimitra, Koumprentziotis, Ioannis-Alexios, Xynos, Georgios, Gogas, Helen
Publicado 2023

Neuromuscular Complications of Targeted Anticancer Agents: Can Tyrosine Kinase Inhibitors Induce Myasthenia Gravis? Getting Answers From a Case Report up to a Systematic Review

por Ziogas, Dimitrios C., Mandellos, Dimitrios, Theocharopoulos, Charalampos, Lialios, Panagiotis-Petros, Bouros, Spyros, Ascierto, Paolo A., Gogas, Helen
Publicado 2021